Cargando…

An overview of FDA regulated products : from drugs and cosmetics to food and tobacco /

Today's challenge, especially for many newcomers to the regulated industry, is not necessarily to gather regulatory information, but to know how to interpret and apply it. The ability to discern what is important from what is not, and to interpret regulatory documents correctly, provides a valu...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Pacifici, Eunjoo (Editor ), Bain, Susan (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: London : Academic Press, [2018]
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000 i 4500
001 SCIDIR_on1041139748
003 OCoLC
005 20231120010301.0
006 m o d
007 cr cnu|||unuuu
008 180620t20182018enk ob 001 0 eng d
040 |a N$T  |b eng  |e rda  |e pn  |c N$T  |d N$T  |d YDX  |d EBLCP  |d OPELS  |d OCLCF  |d OTZ  |d MERER  |d NLE  |d U3W  |d OCLCQ  |d LVT  |d D6H  |d BRX  |d OCLCQ  |d OCLCO  |d OCLCQ  |d S2H  |d OCLCO  |d CASUM  |d OCLCO  |d OCLCQ  |d OCLCO  |d K6U  |d OCLCQ  |d GPM  |d OCL  |d OCLCO 
019 |a 1041896252  |a 1042394161 
020 |a 9780128111567  |q (electronic bk.) 
020 |a 0128111569  |q (electronic bk.) 
020 |z 9780128111550 
020 |z 0128111550 
035 |a (OCoLC)1041139748  |z (OCoLC)1041896252  |z (OCoLC)1042394161 
043 |a n-us--- 
050 4 |a HF5415.153  |b .O94 2018 
072 7 |a BUS  |x 082000  |2 bisacsh 
072 7 |a BUS  |x 041000  |2 bisacsh 
072 7 |a BUS  |x 042000  |2 bisacsh 
072 7 |a BUS  |x 085000  |2 bisacsh 
082 0 4 |a 658.5/75  |2 23 
245 0 3 |a An overview of FDA regulated products :  |b from drugs and cosmetics to food and tobacco /  |c edited by Eunjoo Pacifici, Susan Bain. 
264 1 |a London :  |b Academic Press,  |c [2018] 
264 4 |c �2018 
300 |a 1 online resource (xxi, 268 pages) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
504 |a Includes bibliographical references and index. 
588 0 |a Online resource; title from PDF title page (EBSCO, viewed June 21, 2018). 
505 0 |a Cover; Title page; Copyright page; Dedication; Contents; Contributors; Foreword; Preface; Acknowledgments; Chapter 1 -- Introduction to FDA-regulated products; Chapter objectives; 1.1 -- What is a regulated product?; 1.2 -- How are different products regulated?; 1.3 -- Product classification; 1.4 -- History of the modern regulatory system; 1.4.1 -- Adulteration and misbranding; 1.4.2 -- Safety; 1.4.3 -- Efficacy; 1.4.4 -- Regulation of medical devices; 1.4.5 -- User fees; 1.5 -- Focus on postmarketing oversight; 1.6 -- The modern regulatory system; References 
505 8 |a Chapter 2 -- Regulatory agencies of the ICH: authorities, structures, and functionsChapter objectives; 2.1 -- Introduction; 2.2 -- United states of america: food and drug administration; 2.2.1 -- Establishing a regulatory mechanism; 2.2.2 -- What is fda's mission?; 2.2.3 -- How is the fda structured?; 2.2.4 -- Medical products; 2.2.5 -- Legal framework; 2.2.6 -- Fda's functions; 2.2.6.1 -- Permitting unapproved products to undergo testing in humans; 2.2.6.2 -- Reviewing applications for marketing; 2.2.6.2.1 -- Drugs; 2.2.6.2.2 -- Biologics; 2.2.6.2.3 -- Medical devices; 2.2.6.3 -- Pharmacovigilance 
505 8 |a 2.2.7 -- OTHER PRODUCTS2.2.7.1 -- Veterinary products; 2.2.7.2 -- Food; 2.2.7.3 -- Cosmetics; 2.2.7.4 -- Tobacco products; 2.3 -- JAPAN: PHARMACEUTICALS AND MEDICAL DEVICES AGENCY (PMDA); 2.3.1 -- MISSION; 2.3.1.1 -- Reviews; 2.3.1.2 -- Safety measures; 2.3.1.3 -- Relief services for patients suffering from adverse health effects; 2.3.2 -- SCOPE; 2.3.3 -- ORGANIZATION STRUCTURE; 2.3.4 -- PRIMARY REGULATORY FUNCTIONS; 2.3.5 -- NOTEWORTHY REGULATORY PROVISIONS; 2.3.5.1 -- Special regulatory pathway for regenerative medicine; 2.3.5.2 -- Drug master file system 
505 8 |a 2.3.5.3 -- Accelerated regulatory pathway for innovative products2.3.5.4 -- Accredited foreign manufacturer; 2.3.6 -- MEDICAL DEVICES; 2.3.7 -- QUASIDRUGS; 2.3.8 -- COSMETICS; 2.3.9 -- ORPHAN PRODUCTS; 2.3.10 -- POSTMARKETING SAFETY MEASURE; 2.3.10.1 -- Early postmarketing phase vigilance; 2.3.10.2 -- Mihari project; 2.3.10.3 -- Relief services for adverse health effects; 2.3.11 -- REGULATORY SCIENCE; 2.3.12 -- INTERNATIONAL ACTIVITIES; 2.3.13 -- SUMMARY; 2.4 -- EUROPEAN UNION: EUROPEAN MEDICINES AGENCY; 2.4.1 -- MISSION AND SCOPE; 2.4.2 -- LEGAL FRAMEWORK; 2.4.3 -- CENTRALIZED PROCEDURE 
505 8 |a 2.4.3.1 -- Biotechnology products2.4.3.2 -- Advanced therapies; 2.4.3.3 -- Selected indications; 2.4.4 -- CLINICAL TRIALS; 2.4.4.1 -- Investigational medicinal product application; 2.4.5 -- MEDICAL DEVICES; 2.4.6 -- PHARMACOVIGILANCE; 2.4.6.1 -- Risk management plan (EMA, 2016m); 2.4.6.2 -- Qualified person of pharmacovigilance (QPPV); 2.4.7 -- SUMMARY; 2.5 -- ROLE OF CIOMS AND ICH; 2.5.1 -- CIOMS; 2.5.2 -- ICH; 2.6 -- OVERALL SUMMARY; References; Further ReadingS; Chapter 3 -- Drugs; Chapter Objectives; 3.1 -- Is the product a drug?; 3.2 -- How are drugs categorized? 
505 8 |a 3.3 -- What is a regulatory strategy and what does it entail? 
520 |a Today's challenge, especially for many newcomers to the regulated industry, is not necessarily to gather regulatory information, but to know how to interpret and apply it. The ability to discern what is important from what is not, and to interpret regulatory documents correctly, provides a valuable competitive advantage to any newcomer or established professional in this field. An Overview of FDA Regulated Products: From Drugs and Medical Devices to Food and Tobacco provides a valuable summary of the key information to unveil the meaning of critical, and often complex, regulatory concepts. Concise and easy to read with practical explanations, key points, summaries and case studies, this book highlights the regulatory processes involved in bringing an FDA regulated product from research and development to approval and market. Although the primary focus will be on the US system, this book also features global perspectives where appropriate. A valuable resource for students, professors and professionals, An Overview of FDA Regulated Products illustrates the most important elements and concepts so that the reader can focus on the critical issues and make the necessary connections to be successful. 
610 1 0 |a United States.  |b Food and Drug Administration. 
650 0 |a New products  |z United States. 
650 0 |a Manufactures  |z United States. 
650 0 |a Cosmetics. 
650 0 |a Food. 
650 0 |a Tobacco. 
650 1 2 |a Device Approval  |0 (DNLM)D018795 
650 1 2 |a Drug Approval  |0 (DNLM)D017277 
650 1 2 |a nomesh 
650 2 2 |a Consumer Product Safety  |0 (DNLM)D003257 
650 2 2 |a Cosmetics  |0 (DNLM)D003358 
650 2 2 |a Food  |0 (DNLM)D005502 
650 2 2 |a Government Regulation  |0 (DNLM)D033161 
650 2 2 |a Tobacco  |0 (DNLM)D014026 
650 6 |a Cosm�etiques.  |0 (CaQQLa)201-0006079 
650 6 |a Aliments.  |0 (CaQQLa)201-0001973 
650 6 |a Tabac.  |0 (CaQQLa)201-0017732 
650 7 |a cosmetics.  |2 aat  |0 (CStmoGRI)aat300236306 
650 7 |a food.  |2 aat  |0 (CStmoGRI)aat300254496 
650 7 |a tobacco (material)  |2 aat  |0 (CStmoGRI)aat300011896 
650 7 |a BUSINESS & ECONOMICS  |x Industrial Management.  |2 bisacsh 
650 7 |a BUSINESS & ECONOMICS  |x Management.  |2 bisacsh 
650 7 |a BUSINESS & ECONOMICS  |x Management Science.  |2 bisacsh 
650 7 |a BUSINESS & ECONOMICS  |x Organizational Behavior.  |2 bisacsh 
610 1 7 |a United States.  |b Food and Drug Administration  |2 fast  |0 (OCoLC)fst00549734 
650 7 |a Tobacco  |2 fast  |0 (OCoLC)fst01432109 
650 7 |a Food  |2 fast  |0 (OCoLC)fst00930458 
650 7 |a Cosmetics  |2 fast  |0 (OCoLC)fst00880500 
650 7 |a Manufactures  |2 fast  |0 (OCoLC)fst01007993 
650 7 |a New products  |2 fast  |0 (OCoLC)fst01036889 
651 7 |a United States  |2 fast  |0 (OCoLC)fst01204155 
655 4 |a Internet Resources. 
700 1 |a Pacifici, Eunjoo,  |e editor. 
700 1 |a Bain, Susan,  |e editor. 
776 0 8 |i Print version:  |z 0128111550  |z 9780128111550  |w (OCoLC)1011516845 
856 4 0 |u https://sciencedirect.uam.elogim.com/science/book/9780128111550  |z Texto completo